Answers are grounded in this paper and cite their sources.
OBJECTIVE: Evidence suggests more persistent heavy drinking and alcohol use disorders among Latinx/Hispanic, Black, and American Indian/Alaska Native (AIAN) (vs. White) subpopulations. While lower mutual-help group (MHG) participation may contribute to these differences, clinical studies describing associations between race/ethnicity and MHG participation are lacking. METHOD: We analyzed sociodemographic correlates of weekly MHG attendance in the 30 days preceding treatment discharge among adults of White, Latinx/Hispanic, Black, AIAN, Asian/Pacific Islander (Asian/PI), and Other race/ethnicity in the 2015-2022 Treatment Episodes Data (N=2,799,747), focusing on race/ethnicity and sex. Analyses were logistic regressions stratified by setting, including respondents reporting alcohol as a primary, secondary, or tertiary substance. RESULTS: Across settings, adjusted odds of weekly MHG attendance were significantly lower for Latinx/Hispanic (aORs=0.61-0.64), Black (aORs=0.72), AIAN (aORs=0.72-0.78), and Other (aORs=0.89-0.90) (vs. White) discharges, but higher among Asian/PI (aORs=1.60-1.66) (vs. White) discharges. Sex modified these differences slightly, and overall females showed higher adjusted odds of weekly attendance across settings. Other characteristics consistently associated with lower adjusted odds of weekly attendance included age 18-24 or 65+ (vs. 45-54), married (vs. unmarried) status, lower (vs. higher) education, and employment (vs. unemployment). Recency of discharge year showed a roughly linear, negative association with weekly MHG attendance. CONCLUSIONS: Our study documented diminished MHG utilization among nearly all racial/ethnic minority (vs. White) subgroups, with additional sociodemographic differences emerging and weekly MHG attendance declining steeply with time. Because MHG attendance substantially increases treatment effectiveness, enhancing MHG engagement during treatment, for example through tailored facilitation, may help ensure optimal outcomes for all treatment-seekers.
No takes yet. Share an insight, caveat, or question.
Zemore et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: